Teva Loses Bid For Sales Ban On Generic Copaxone
A New York federal judge on Tuesday rejected Teva Pharmaceuticals USA Inc.'s bid to block sales of generic versions of its multiple sclerosis drug Copaxone following a recent U.S. Supreme Court...To view the full article, register now.
Already a subscriber? Click here to view full article